Latest Articles

Publication Date
Taurine alleviates oxidative stress, inflammation, and mitochondrial apoptosis in lipopolysaccharide-induced bovine endometrial epithelial cells by activating Nrf2/HO-1 and inhibiting TLR4-MAPK/NF-κB and Caspase-3 pathways - ScienceDirect.com

Taurine alleviates oxidative stress, inflammation, and mitochondrial apoptosis in lipopolysaccharide-induced bovine endometrial epithelial cells by activating Nrf2/HO-1 and inhibiting TLR4-MAPK/NF-κB and Caspase-3 pathways ScienceDirect.com

Published: July 22, 2025, 5:55 p.m.
'A real turning point': Endometriosis advocates bring your stories to health minister - NationalWorld

'A real turning point': Endometriosis advocates bring your stories to health minister NationalWorld

Published: July 22, 2025, 5:20 p.m.
Meet the inspiring woman on a mission to help others living with endometriosis - I Love Manchester

Meet the inspiring woman on a mission to help others living with endometriosis I Love Manchester

Published: July 22, 2025, 3:19 p.m.
'A real turning point': Endometriosis advocates bring your stories to health minister - DerbyWorld

'A real turning point': Endometriosis advocates bring your stories to health minister DerbyWorld

Published: July 22, 2025, 2:53 p.m.
'A real turning point': Endometriosis advocates bring your stories to health minister - Yorkshire Post

'A real turning point': Endometriosis advocates bring your stories to health minister Yorkshire Post

Published: July 22, 2025, 2:53 p.m.
'A real turning point': Endometriosis advocates bring your stories to health minister - The Scotsman

'A real turning point': Endometriosis advocates bring your stories to health minister The Scotsman

Published: July 22, 2025, 2:53 p.m.
UK femtech startup Daye secures patent for its organic plastic-free diagnostic & menstrual tampons - Silicon Canals

UK femtech startup Daye secures patent for its organic plastic-free diagnostic & menstrual tampons Silicon Canals

Published: July 22, 2025, 1:58 p.m.
Gesynta Pharma Announces Second Closing of Series B Now Totaling SEK 347m - HealthCap and Hadean Growth Fund Join Strong Investor Syndicate - beQuoted

Gesynta Pharma Announces Second Closing of Series B Now Totaling SEK 347m - HealthCap and Hadean Growth Fund Join Strong Investor Syndicate beQuoted

Published: July 22, 2025, 10 a.m.
Analysis of postoperative prognosis of non-metastatic endometrial carcinoma under different recurrence patterns - Nature

Analysis of postoperative prognosis of non-metastatic endometrial carcinoma under different recurrence patterns Nature

Published: July 22, 2025, 8:14 a.m.
A Complex Case Report of OHVIRA syndrome: Uterine didelphys, obstructed hemivagina, and renal agenesis.

Obstructed hemivagina and ipsilateral renal anomaly (OHVIRA) syndrome, also known as Herlyn-Werner-Wunderlich syndrome, is a rare congenital anomaly resulting from abnormal development of the Müllerian and Wolffian ducts, characterized by …

Published: July 22, 2025, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!